The Role of Melatonin in the Effective Attainment of Sleep Electroencephalograms (EEG) in Children

NCT02195661 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 194

Last updated 2017-11-30

No results posted yet for this study

Summary

This study aims to determine the safety and effectiveness of oral melatonin as natural inducer of sleep to acquire useful EEGs in South African children following its introduction as the main agent used in the Neurophysiology department at Red Cross Children's Hospital. This is an observational retrospective study.

Conditions

  • Epilepsy
  • Electroencephalogram
  • Children
  • Sedation

Interventions

DIETARY_SUPPLEMENT

Melatonin

DRUG

Chloral Hydrate

Sponsors & Collaborators

  • University of Cape Town

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2017-09-30
Completion
2017-10-31

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02195661 on ClinicalTrials.gov